Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

T KING

Showing results (1011-1020 of 1,347) with videos related to

Pageof 135
Sort By:
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Science (New York, N.Y.)|May 15, 2025
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposaseIsaac P Witte, George D Lampe, Simon Eitzinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Regulatory Toxicology and Pharmacology : RTP|May 20, 2023
Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assaysXilin Li, Yuan Le, Ji-Eun Seo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 18, 2017
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancerMadeleine T King, Martin R Stockler, Rachel L O'Connell, et al.
Nature Communications|March 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannomaAdam P Jones, Michael J Haley, Miriam H Meadows, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
Burns : Journal of the International Society for Burn Injuries|July 11, 2026
Medical response framework for catastrophic burn and radiation mass casualties after a potential Ukraine nuclear eventMark Ervin, Booker T King, Leopoldo C Cancio, et al.
Stem Cells and Development|May 17, 2022
Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated RemodelingKatie M Hamel, Connor T King, Maryn B Cavalier, et al.
Pageof 135

Showing results (1011-1020 of 1,347) with videos related to

Sort By:
Pageof 135
International Journal of Radiation Oncology, Biology, Physics|May 3, 2017
National Trends and Predictors of Androgen Deprivation Therapy Use in Low-Risk Prostate CancerDavid D Yang, Vinayak Muralidhar, Brandon A Mahal, et al.
Brachytherapy|September 12, 2021
Low dose rate brachytherapy for primary treatment of localized prostate cancer: A systemic review and executive summary of an evidence-based consensus statementMartin T King, Mira Keyes, Steven J Frank, et al.
Science (New York, N.Y.)|May 15, 2025
Programmable gene insertion in human cells with a laboratory-evolved CRISPR-associated transposaseIsaac P Witte, George D Lampe, Simon Eitzinger, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 19, 2025
CT online adaptive radiotherapy is associated with dosimetric and acute toxicity improvements in prostate cancer treatmentLin L Zhu, Jeremy S Bredfeldt, Yue-Houng Hu, et al.
Regulatory Toxicology and Pharmacology : RTP|May 20, 2023
Revisiting the mutagenicity and genotoxicity of N-nitroso propranolol in bacterial and human in vitro assaysXilin Li, Yuan Le, Ji-Eun Seo, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation|December 18, 2017
Measuring what matters MOST: validation of the Measure of Ovarian Symptoms and Treatment, a patient-reported outcome measure of symptom burden and impact of chemotherapy in recurrent ovarian cancerMadeleine T King, Martin R Stockler, Rachel L O'Connell, et al.
Nature Communications|March 27, 2025
Spatial mapping of immune cell environments in NF2-related schwannomatosis vestibular schwannomaAdam P Jones, Michael J Haley, Miriam H Meadows, et al.
Biorxiv : the Preprint Server for Biology|June 6, 2025
Immune Spatial Organization Predicts Metastasis Risk in Aggressive Localized Prostate CancerDavid D Yang, Aya Abdelnaser, Jeremiah Wala, et al.
Burns : Journal of the International Society for Burn Injuries|July 11, 2026
Medical response framework for catastrophic burn and radiation mass casualties after a potential Ukraine nuclear eventMark Ervin, Booker T King, Leopoldo C Cancio, et al.
Stem Cells and Development|May 17, 2022
Breast Cancer-Stromal Interactions: Adipose-Derived Stromal/Stem Cell Age and Cancer Subtype Mediated RemodelingKatie M Hamel, Connor T King, Maryn B Cavalier, et al.
Pageof 135